Vaccine‐incentivized blood donation: A survey of public perceptions in Canada

Abstract

AbstractBackground and ObjectivesCanadian blood donations declined during the start of the COVID‐19 pandemic. Conversely, vaccine demand outpaced supply during the initial stages of the COVID‐19 vaccine rollout in Canada. This study investigates public perceptions regarding vaccine‐incentivized blood donation, among COVID‐19 and future pandemics, in Canada.Materials and MethodsA 19‐question survey was developed and distributed in person and online to Canadians during the third wave of the COVID‐19 pandemic. Participants were asked questions about demographics, blood donation eligibility, previous donations and sentiments towards vaccine‐incentivized blood donation. Data were analysed using descriptive statistics.ResultsIn total, 787 respondents completed the survey with representation from all sexes, ages, races, locations of residence and work employment. Overall, 176 (22%) participants self‐identified as working or living in healthcare settings, 511 (65%) were currently able to donate blood products, 247 (31%) previously donated blood and 48 (6%) donated blood during the COVID‐19 pandemic. With the exception of ineligible blood donors, many Canadians, particularly previous blood donors, were agreeable with this incentivization proposal. Many participants claimed they would donate blood products for vaccines during COVID‐19 and future pandemics but raised concerns about the equitableness of such approach.ConclusionVaccine‐incentivized blood donation was viewed positively by many Canadians in our study. Future research must investigate the equity and feasibility of this strategy. In the interim, further strategies should be explored to encourage blood donation in Canada.